Celebrity Names: John Stamos & Jodie Sweetin
Brand Name: Cologuard / Abbott
Deal Type: Brand Partnership / Awareness Campaign
Announced: March 24, 2026
Impact: Positions Cologuard at the center of a culturally resonant conversation on early detection, while extending both stars’ relevance as trusted, multi‑platform advocates for family health
- Full House favorites John Stamos and Jodie Sweetin are starring in Abbott’s “The (Second) Talk” campaign, encouraging adults 45 and older to screen for colorectal cancer using the Cologuard test, launched March 24, 2026, during Colorectal Cancer Awareness Month.
- The Cologuard test is FDA-approved, noninvasive, prescribed by a healthcare provider, and shipped directly to a patient’s home, requiring no special preparation or dietary changes.
- Colorectal cancer is the second-leading cause of cancer-related deaths in the U.S., and the number one cancer killer among adults under 50, with a 91% five-year survival rate when detected early.
- The campaign, created by agency Blue Hour, spans organic and paid social, streaming audio, and out-of-home placements with QR codes, and is expected to run through the end of April.
Abbott has reunited beloved Full House co-stars John Stamos and Jodie Sweetin for a new Cologuard campaign called “The (Second) Talk,” a nostalgic, sitcom-style skit encouraging adults 45 and older to get screened for colorectal cancer.
In the campaign video, Sweetin plays a character who has just turned 45 but feels awkward about starting colon cancer screenings, while Stamos, armed with a Cologuard box billed as a “special guest star,” steps in to reassure her the process is simple and non-invasive.
Stamos says the role feels personal. The actor has used the Cologuard test himself and calls it “easy, done, peace of mind.”
Away from the campaign, Stamos recently appeared in the second season of Palm Royale, has wrapped filming on The Hunting Wives, and is hitting the road with the Beach Boys this month.
Sweetin, meanwhile, co-hosts the Full House rewatch podcast How Rude, Tanneritos! with Andrea Barber and is bringing her comedy show Smoke Show with Jodie Sweetin to the Netflix Is a Joke Festival on May 9.
Just as Will Ferrell brought humor to a major PayPal campaign and Amanda Seyfried leveraged her platform for a global brand push with Hanwha Vision, Stamos and Sweetin are proving that trusted celebrity voices, rooted in nostalgia, can make even the most uncomfortable health topics feel approachable.
The campaign, created by agency Blue Hour, runs across paid and organic social media, streaming audio, and out-of-home placements through the end of April.
Takeaways
This campaign is a masterclass in authentic celebrity casting. Stamos personally uses the Cologuard test, which shifts the dynamic from a standard endorsement to a genuine recommendation, while Sweetin, not yet 45, speaks to the not-yet-thinking-about-it audience, together covering both segments of the target demographic.
Abbott didn’t just pick two recognizable faces, they picked two faces that audiences have literally grown up trusting in their living rooms for 40 years.
The timing is equally sharp. The campaign launched on March 24, 2026, squarely in Colorectal Cancer Awareness Month, amplifying the message where it has the most cultural resonance.
And with Abbott having just completed its acquisition of Exact Sciences, the company behind Cologuard, this campaign also signals how Abbott intends to grow and market the brand moving forward.
Does a celebrity actually using a product make you more likely to trust their endorsement or does it still feel like paid promotion? How does this campaign compare to other health-awareness partnerships you’ve seen; does humor make difficult health topics easier to engage with, or does it minimize the seriousness?
